文献速递心力衰竭与心肌病心律失常

FLNC截短突变与高危扩张型及致心律失常性心肌病相关

Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies.
PubMed 文献 · J Am Coll Cardiol · 2016-01-01

研究对2877例遗传性心血管病患者行FLNC基因检测,在28个家系先证者中检出23个截短突变,确立以左室扩张、收缩功能障碍、心肌纤维化、室性心律失常及频发心源性猝死为特征的扩张型与左优势致心律失常性心肌病重叠表型,>40岁携带者外显率>97%。

要点

  • FLNC截短突变见于扩张型、致心律失常性或限制型心肌病先证者,肥厚型心肌病患者中未检出。
  • 表型包括左室扩张68%、收缩功能障碍46%、心肌纤维化67%、室性心律失常82%。
  • 作者认为,携带FLNC截短突变的受累患者应考虑及早植入心脏除颤器。

核心结论

  • FLNC截短突变导致扩张型与左优势致心律失常性心肌病的重叠表型,并并发频发早发心源性猝死。

研究设计与样本

  • 采用二代测序对2877例遗传性心血管疾病患者进行FLNC基因检测,并对28个受累家系进行临床与遗传评估。
  • 对携带FLNC截短突变的患者心肌组织行免疫组化分析,定位filamin C。

主要发现

  • 在28例既往诊断为扩张型、致心律失常性或限制型心肌病的先证者中鉴定出23个截短突变,包括1078例肥厚型心肌病在内的其他表型患者中未检出FLNC截短突变。
  • 在121名筛查亲属中检出54名突变携带者,表型包括左室扩张68%、收缩功能障碍46%、心肌纤维化67%。
  • 心电图示下侧壁T波倒置及低QRS电压者占33%,室性心律失常占82%,28个家系中21个家系共发生40例心源性猝死。
  • 未观察到临床骨骼肌病,>40岁携带者外显率>97%,截短突变与该表型以显性遗传模式共分离(复合LOD评分9.5)。
  • 对突变携带者心肌组织行免疫组化染色,未显示异常的filamin C聚集。

临床怎么用

  • 作者认为,携带FLNC截短突变的受累患者应考虑及早植入心脏除颤器。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Filamin C (encoded by the FLNC gene) is essential for sarcomere attachment to the plasmatic membrane. FLNC mutations have been associated with myofibrillar myopathies, and cardiac involvement has been reported in some carriers. Accordingly, since 2012, the authors have included FLNC in the genetic screening of patients with inherited cardiomyopathies and sudden death. OBJECTIVES: The aim of this study was to demonstrate the association between truncating mutations in FLNC and the development of high-risk dilated and arrhythmogenic cardiomyopathies. METHODS: FLNC was studied using next-generation sequencing in 2,877 patients with inherited cardiovascular diseases. A characteristic phenotype was identified in probands with truncating mutations in FLNC. Clinical and genetic evaluation of 28 affected families was performed. Localization of filamin C in cardiac tissue was analyzed in patients with truncating FLNC mutations using immunohistochemistry. RESULTS: Twenty-three truncating mutations were identified in 28 probands previously diagnosed with dilated, arrhythmogenic, or restrictive cardiomyopathies. Truncating FLNC mutations were absent in patients with other phenotypes, including 1,078 patients with hypertrophic cardiomyopathy. Fifty-four mutation carriers were identified among 121 screened relatives. The phenotype consisted of left ventricular dilation (68%), systolic dysfunction (46%), and myocardial fibrosis (67%); inferolateral negative T waves and low QRS voltages on electrocardiography (33%); ventricular arrhythmias (82%); and frequent sudden cardiac death (40 cases in 21 of 28 families). Clinical skeletal myopathy was not observed. Penetrance was >97% in carriers older than 40 years. Truncating mutations in FLNC cosegregated with this phenotype with a dominant inheritance pattern (combined logarithm of the odds score: 9.5). Immunohistochemical staining of myocardial tissue showed no abnormal filamin C aggregates in patients with truncating FLNC mutations. CONCLUSIONS: Truncating mutations in FLNC caused an overlapping phenotype of dilated and left-dominant arrhythmogenic cardiomyopathies complicated by frequent premature sudden death. Prompt implantation of a cardiac defibrillator should be considered in affected patients harboring truncating mutations in FLNC.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Ortiz-Genga MF, Cuenca S, Dal Ferro M, et al. Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies. J Am Coll Cardiol. 2016. PMID: 27908349. doi:10.1016/j.jacc.2016.09.927

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。